Results 51 to 60 of about 23,059 (205)

Ethical and legal issues in psychedelic harm reduction and integration therapy

Harm Reduction Journal, 2021
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits.
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea, Vilmarie Fraguada Narloch   +4 more
doaj   +1 more source

Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder

Frontiers in Psychiatry
Psychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric ...
Scott Matthews, Scott Matthews, Antonino Greco, Antonino Greco, Antonino Greco, Antonino Greco, Clara Rastelli, Clara Rastelli, Clara Rastelli, Anahita Bassir Nia, Anahita Bassir Nia, Anahita Bassir Nia   +11 more
doaj   +1 more source

Pasifika Healthcare Workers' Perspectives of Psychedelic-Assisted Therapy

, 2023
Recent studies indicate that psychedelic-assisted therapy may assist with various psychological issues, including depression, anxiety, and existential distress.
Nuha, Musheerah
core  

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

Frontiers in Psychiatry, 2021
Background: Chronic Pain is among the leading causes of disability worldwide with up to 60% of patients suffering from comorbid depression. Psychedelic-assisted therapy has recently been found effective in treating a host of mental health issues ...
Julia Bornemann, James B. Close, Meg J. Spriggs, Robin Carhart-Harris, Robin Carhart-Harris, Leor Roseman   +5 more
doaj   +1 more source

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le, Sabrina Wong, Danica E. Johnson, Diana K. Orsini, Yang Jing Zheng, Kayla M. Teopiz, Christine E. Dri, Joshua D. Rosenblat, Roger S. McIntyre   +8 more
wiley   +1 more source

Psychedelic Therapy: Beyond Brain, Embracing Culture

, 2023
This paper argues that cultural embodiment plays a pivotal factor in shaping psychological experiences, influencing both the development and treatment of mental health conditions.
Sofia Tzima, ‪Inês Hipólito‬
core   +1 more source

Psychedelic-assisted therapy: An overview for the internist

Cleveland Clinic Journal of Medicine
Preliminary evidence suggests that psychedelic-assisted therapy-the enhancement of psychotherapy with psychedelics such as 3,4-methylenedioxymethamphet-amine (MDMA) and psilocybin-may be efficacious for depression, posttraumatic stress disorder, substance use disorders, and other conditions.
Brian S, Barnett, Erin E, Mauney, Franklin, King   +2 more
openaire   +2 more sources

Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review

Journal of Clinical Psychology, EarlyView.
ABSTRACT Recent studies have shown promising results for psychedelics in the treatment of psychiatric disorders. Both in clinical and recreational settings, contextual elements, such as music, can influence the experience of users and may be linked to positive outcomes.
Lucas Cruz, Fernando R. Beserra, Julia M. K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi   +4 more
wiley   +1 more source

Creating Greater Safety in Psychedelic-Assisted Therapy Spaces

, 2023
As the medical legalization of psychedelic-assisted therapy quickly approaches in Western society, more stories of abuse by psychedelic therapists against clients are emerging, tracing a disturbing pattern and history of exploitation and abuses of power ...
Maira Evelyn Clancy
core  

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source